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Summary 20 
 A 12 year old Thoroughbred cross Dartmoor mare was referred to the clinic with 21 
marked lameness and swelling involving the left stifle region. There was poor initial response 22 
to medical management and therefore arthroscopic examination of the stifle joint was 23 
performed under general anaesthesia. Following surgery, the lameness and swelling worsened  24 
and extremity compartment syndrome was suspected. A multimodal analgesia protocol was 25 
instigated to provide adequate analgesia and improved mobility, aiding the use of physical 26 
therapy in resolving the swelling. This report demonstrates the successful combination of 27 
non-steroidal anti-inflammatories, paracetamol, ketamine infusion and epidural opioid 28 
administration to manage the clinical signs. The mare was discharged from hospital after 15 29 
days and at short-term (three months) follow-up, there was no reported residual swelling or 30 
lameness.  31 
Introduction 32 
 Compartment syndrome occurs when increased pressure within a tissue in an enclosed 33 
space compromises visceral and neuromuscular function within that area (Rorabeck and 34 
McGee, 1990). This increased tissue pressure restricts local perfusion, leading to physiologic 35 
dysfunction of cells, including cytokine release and oxygen free radical formation, ultimately 36 
resulting in cell death (Vegar-Brozovic and Stoic-Brezak, 2006). Compartment syndrome 37 
may occur directly as a result of the disease process itself (haemorrhage, oedema, 38 
thrombosis) or iatrogenically as a result of external compression from improper surgical 39 
positioning, constrictive bandages or excessive fluid resuscitation (Nielsen and Whelan, 40 
2012). Definitive diagnosis requires measurement of intra-compartmental pressure using a 41 
needle and manometer, wick catheter, slit catheter or non-invasive, near-infrared 42 
spectroscopy (Rorabeck and McGee, 1990, Garr et al., 1999, Nielsen and Whelan, 2012). In a 43 
clinical setting however, these tools may not be available and therefore diagnosis is usually 44 
based on history and clinical signs consistent with compartment syndrome (Rorabeck and 45 
McGee, 1990, Nielsen and Whelan, 2012). 46 
 Compartment syndromes are well-recognised in human medicine and have been 47 
documented in the thorax, abdomen and limb extremities (Nielsen and Whelan, 2012). 48 
Skeletal muscle or extremity compartment syndrome (ECS) is the most widely recognised 49 
type in veterinary medicine and involves increases in pressure within fascial compartments 50 
surrounding limb muscles (Nielsen and Whelan, 2012). Literature in the veterinary field is 51 
mainly confined to case reports (Sullins et al., 1987, Dodman et al., 1988, Norman et al., 52 
1989, Nelson et al., 2015) but intra-compartmental muscle pressures have been measured 53 
experimentally in horses (Lindsay et al., 1985, McDonell et al., 1985, Nielsen and Whelan, 54 
2012). Clinical signs of ECS include severe pain disproportionate to that expected for the 55 
injuries sustained, paresis, tenseness of the limb and weak or absent pulses in the affected 56 
area (Rorabeck and McGee, 1990, Nielsen and Whelan, 2012). Effective management of 57 
associated pain is essential and treatment with surgical decompression via fasciotomy is often 58 
required (Bae et al., 2001). Development of lumbosacral radiculoplexopathy and complex 59 
regional pain syndrome secondary to gluteal compartment syndrome was recently reported in 60 
the human literature, highlighting the potential for progression to chronic pain syndromes in 61 
these cases (Lederman et al., 2016). 62 
 Femoral compartment syndrome secondary to intramuscular haemangiosarcoma has 63 
been described in two dogs (Bar-Am et al., 2006, Radke et al., 2006). There has also been a 64 
report of acute ECS development in the stifle region of a Holstein cow following biopsy of an 65 
intramuscular haemangiosarcoma (Vogel et al., 2012). In equine medicine, ECS is most 66 
commonly reported associated with post-anaesthetic myopathy, particularly in the gluteal and 67 
triceps muscles (Sullins et al., 1987, Dodman et al., 1988, Norman et al, 1989, Kobluk 1995), 68 
but has been described in the forelimb antebrachial region of two horses secondary to trauma 69 
at pasture (Nelson et al., 2015). 70 
To the authors' knowledge, this is the first case report of suspected ECS secondary to trauma 71 
in the pelvic limb of a horse and describes the pivotal role of multimodal pain management in 72 
the successful outcome of this case.  73 
Case History 74 
 A 12 year old Thoroughbred cross Dartmoor mare was referred to the clinic following 75 
a three day history of swelling around the left stifle with progressively worsening lameness, 76 
secondary to a suspected traumatic episode. Treatment prior to referral had included 77 
1.1mg/kg bwt flunixin (Finadyne)1 intravenously (IV), 12mg/kg bwt procaine 78 
benzylpenicillin (Depocillin)2 intramuscularly (IM) and 6.6mg/kg bwt gentamicin (Genta-79 
Equine)3 IV. No bony abnormalities were identified on radiography by the referring 80 
veterinary surgeon but synoviocentesis of the left femoropatellar joint yielded sanguinous 81 
fluid on two subsequent days.  82 
Clinical Findings 83 
 On presentation, the mare was moderately lame (6/10, Stashak, 2002) on the left 84 
pelvic limb at walk with marked swelling in the craniolateral stifle region. Flexion, extension 85 
and abduction of the limb were tolerated. No wounds were present on examination and all 86 
other findings were within normal limits.  87 
 Ultrasonographic examination (Logiq S7 Expert)4 revealed moderate fluid distension 88 
of the left femoropatellar joint and peri-articular subcutaneous swelling over the craniolateral 89 
stifle. Intra- and peri-articular fluid were of mixed echogenicity, consistent with 90 
haemarthrosis and peri-articular haemorrhage (Figure 1). No abnormalities were detected in 91 
the patellar ligaments or collateral ligaments of the stifle. No abnormalities were found on 92 
evaluation of the medial and lateral femorotibial joints. Synoviocentesis of the left 93 
femoropatellar joint yielded a sanguinous sample consistent with haemarthrosis (Table 1). 94 
Treatment 95 
 On admission to the clinic, medical management was continued (20mg/kg bwt 96 
procaine benzylpenicillin IM q. 12 h, 6.6mg/kg bwt gentamicin IV q. 24 h and 4.4mg/kg 97 
phenylbutazone (Equipalazone)5 IV q. 12 h.) combined with walking in hand for 1-2 minutes 98 
three times a day. As no clinical improvement was evident after 24 hours, arthroscopic 99 
evaluation of the left femoropatellar joint was performed under general anaesthesia. At 100 
surgery, marked synovial inflammation was identified. After arthroscopic lavage with 20 101 
litres of sterile, polyionic, isotonic crystalloid fluid (Aqupharm-11)6, resection of reactive 102 
synovium was performed followed by medication of the femoropatellar joint with 0.44mg/kg 103 
bwt amikacin (Amikacin)7 and 0.11mg/kg bwt bupivacaine (Marcain 0.5%)8. An extra-104 
articular haematoma on the craniolateral stifle was also drained. Fluid aspirated from the 105 
haematoma and biopsies taken from the synovium were submitted for microbiological 106 
culture. Phenylbutazone 4.4mg/kg bwt IV q. 12 h was administered and antimicrobials were 107 
continued at previous doses whilst awaiting microbiological culture results. 108 
 Over the following 24 hours, the level of lameness significantly worsened (9/10) with 109 
marked subcutaneous oedema around the stifle extending dorsally into the inguinal area. The 110 
distal sutures of the portal incisions were removed to assist drainage (Figure 2) and cold 111 
packing and cold hosing of the affected area were commenced. In addition to 112 
phenylbutazone, 0.2mg/kg morphine (Morphine sulphate)9 was administered IV q. 4 h and 113 
20mg/kg paracetamol (Paracetamol)10 was commenced orally (PO) q. 12 h.  114 
 The following day, there was a mild reduction in swelling around the stifle and 115 
associated area and 0.1mg/kg bwt dexamethasone (Dexadreson)11 IV was administered. 116 
Haematological and clotting profiles were performed, revealing a reduction in prothrombin 117 
time (PT) (10 seconds (reference range 15-20s)) and activated partial thromboplastin time 118 
(APTT) (38 seconds (reference range 45-66s)). Haematology was otherwise unremarkable 119 
(Table 2).  120 
 Three days after arthroscopy, the mare's demeanour deteriorated and the horse was 121 
extremely reluctant to walk out of the stable. Due to the lack of improvement in swelling or 122 
degree of pain, development of extremity compartment syndrome (ECS) within the fascial 123 
planes around the femoropatellar joint was suspected.  As dexamethasone resulted in no 124 
clinically appreciable improvement, this treatment was not repeated and as the mare was too 125 
painful for physical therapy to be effective, the analgesic protocol was modified. A 126 
lumbosacral epidural catheter (Perifix®ONE Pediatric Epidural Anesthesia Catheter)12 was 127 
placed (Figure 3) and 60mg (0.13mg/kg bwt) preservative-free morphine (Morphine 128 
Sulphate)13 combined with 50mg (0.11mg/kg bwt) preservative-free methadone 129 
(Physeptone)14, with a total volume of 11mL, were administered via this route. Systemic 130 
opioid analgesia was discontinued and the epidural catheter left in situ. The mare was cross-131 
tied in the stable to prevent premature catheter dislodgement and 60mg preservative-free 132 
morphine was administered epidurally q. 12 h. A ketamine (Anaestamine)15 constant rate 133 
infusion (CRI) was also commenced at 0.8mg/kg bwt/hour.  134 
 No bacterial growth was observed in synovial fluid or synovium following extended 135 
culture (>48 hours). Antimicrobial medication was changed to 5mg/kg bwt trimethoprim and 136 
25mg/kg bwt sulphadiazine (Trimediazine)16 PO q. 12 h. 137 
 Over the next 24 hours, the mare's comfort level and demeanour significantly 138 
improved. The mare was able to ambulate effectively and the swelling around the stifle and 139 
inguinal regions had reduced. The ketamine CRI was discontinued after 24 hours and 140 
epidural morphine administration was reduced to 30mg q. 12 h four days after catheter 141 
placement, before further reduction in dose to 15mg q. 12 h after another two days. 142 
Phenylbutazone was reduced to 2.2mg/kg bwt q.12 h IV after five days of hospitalisation. 143 
Physical therapy was implemented, consisting of local tissue massage and in-hand walking 144 
three times daily for five to 10 minutes initially, increased to 15 minutes over the following 145 
week. Oral paracetamol was discontinued five days after epidural catheter placement. The 146 
epidural catheter was removed after eight days. At this point, the mare was almost sound on 147 
the left pelvic limb with marked reduction in swelling evident (Figure 4). Day to day pain 148 
assessment and analgesic management is summarised in Table 3. 149 
Outcome 150 
 The mare was discharged 15 days after admission to the referral clinic receiving 151 
2.2mg/kg bwt phenylbutazone (Butagran Equi)17 PO q. 12 h and 5mg/kg bwt trimethoprim 152 
with 25mg/kg bwt sulphadiazine PO q. 12 h for four days. Further assessment of lameness 153 
and repeated ultrasonographic examination of the left femoropatellar joint were also 154 
recommended once the swelling had completely resolved.  155 
 At follow-up three months after hospital discharge, the referring veterinary surgeon 156 
reported that the horse was sound in the left pelvic limb at trot in a straight line with no 157 
evidence of lameness after flexion of the left pelvic limb. The owner declined further 158 
ultrasonographic examination. 159 
Discussion 160 
 This report describes the successful management of a suspected case of ECS in the 161 
pelvic limb of a horse. Femoropatellar haemarthrosis and subcutaneous haematoma worsened 162 
after arthroscopic intervention, most likely due to additional subcutaneous oedema formation 163 
in the region. ECS has been described in humans and animals with few case reports detailed 164 
in the horse, although the fascial compartments of the equine proximal pelvic limb have been 165 
described in anatomical literature (Sisson, 1975). Most equine ECS case reports are related to 166 
post-anaesthetic myopathy with the gluteal and triceps muscles being most susceptible 167 
(Norman et al., 1989; Nielsen and Whelan 2009). Surgical decompression via fasciotomy 168 
(Bae et al., 2001) is often required in these cases but appropriate pain management is 169 
paramount for a successful outcome. Through the use of multi-modal pain management, 170 
physical therapy was able to be instigated, assisting in the resolution of the clinical signs in 171 
this case without fasciotomy.   172 
 It is possible that femoropatellar joint sepsis contributed to the pain associated with 173 
this case and antimicrobial medication varied over the course of treatment. Penicillin and 174 
gentamicin are considered first line treatments for synovial sepsis (British Equine Veterinary 175 
Association, 2015), had been administered prior to referral and were continued as synovial 176 
sepsis had not been ruled out on admission. Intra-articular amikacin was administered at 177 
surgery as an alternative aminoglycoside to gentamicin due to reported increases in 178 
gentamicin resistance in equine isolates (Johns and Adams, 2015) and synovial infection 179 
remained a possibility at this stage. Systemic antimicrobial treatment was continued at 180 
previous doses whilst awaiting microbiological culture results.  As no bacterial growth was 181 
observed in synovial fluid or synovium following extended culture, it was considered 182 
unlikely that a septic process was a contributing factor and antimicrobial medication was 183 
changed to trimethoprim and sulphadiazine as a prophylactic measure against ascending 184 
infection via the open arthroscopic  portals. This combination is recommended as a first line 185 
treatment for contaminated limb wounds (British Equine Veterinary Association, 2015). 186 
 Due to the extreme nature of the swelling post-operatively, the chronic nature of the 187 
injury and the indication of initial haemarthrosis, the possibility of a coagulation disorder was 188 
considered. Haematological and biochemical profiles were all within normal limits with the 189 
exception of PT and APTT. Whilst reductions in PT and APTT due to premature activation of 190 
clotting factors may result from technical errors with sample acquisition and storage (Song et 191 
al., 2016), evidence in humans and dogs suggests that shortened PT and APTT may be 192 
associated with hypercoagulability and increased risk of thrombosis (Lippi et al., 2010, Song 193 
et al., 2016). Therefore, PT and APTT could have been measured on subsequent samples to 194 
monitor these changes. 195 
 Compartment syndrome results in cellular hypoxia and necrosis through two proposed 196 
mechanisms. The 'arteriovenous pressure gradient theory' describes how an increase in 197 
venous pressure in a compartment reduces the arteriovenous pressure gradient and hence 198 
reduces oxygen delivery to those tissues (Mars and Hadley, 1998). Ischaemia-reperfusion 199 
injury also occurs where interstitial fluid pressure within a compartment initially rises above 200 
capillary pressure, preventing perfusion of tissues in that compartment. Subsequent 201 
reperfusion leads to production of reactive oxygen species in addition to reduced oxygen 202 
delivery, resulting in a cycle of hypoxia, anaerobic metabolism and further vasoconstriction 203 
which continues to damage cells (Matsen and Krugmire, 1978).  204 
 Compartment syndrome is associated with severe pain due to inflammation, increased 205 
intra-compartmental pressure, ischaemic damage and tissue necrosis. Movement of the 206 
affected limb can help to encourage venous blood flow and hence movement of fluid out of a 207 
particular compartment. In this case, the severity of the pain and swelling precluded physical 208 
therapy of the affected limb, hence augmenting the underlying condition. The key objective 209 
was to modulate the associated pain thus allowing mobilisation of the limb, reduction in 210 
swelling and hence return of function. 211 
 Administration of anti-inflammatories is beneficial in ischaemia-reperfusion injury 212 
(McMicheal, 2004). Studies assessing the effect of non-steroidal anti-inflammatories 213 
(NSAIDs) in experimentally induced ECS in rats and dogs demonstrated increased perfusion 214 
to the affected compartment, decreased muscle necrosis and lower intra-compartmental 215 
pressures (Dabby et al., 1998, Manjoo et al., 2010). Both phenylbutazone and flunixin have 216 
been shown to reduce prostaglandin production in experimentally induced inflammation in 217 
horses (Higgins et al., 1984, Lee and Higgins, 1984) and the efficacy of both drugs has been 218 
demonstrated for musculoskeletal pain (Johnson et al., 1993, Hamm et al., 1997, Kallings et 219 
al., 1999). Phenylbutazone was chosen in this case based on several factors including reduced 220 
cost compared to flunixin and therefore anticipated improved owner compliance with 221 
potential long term treatment. The degree of pain, potential requirement for systemic opioids, 222 
ongoing NSAID treatment, dietary changes and stabling during hospitalisation are 223 
additionally risk factors for developing colic (Senior et al., 2004, Williams et al. 2011, 224 
Scherrer et al., 2016). Flunixin is more likely to mask the cardiovascular changes associated 225 
with endotoxaemia, should this develop as a consequence, potentially delaying identification 226 
and appropriate intervention (King and Gerring, 1989, Mair and Edwards, 1998). Newer 227 
NSAIDs such as firocoxib could have been considered due to demonstrable efficacy in 228 
reducing musculoskeletal pain and potentially improved safety profile with higher cyclo-229 
oxygenase-2 (COX-2) selectivity (Koene et al., 2010, Orsini et al., 2012). There is however 230 
insufficient evidence for superior efficacy or safety of firocoxib compared to phenylbutazone 231 
when used at recommended doses (Doucet et al., 2008). 232 
 Concurrent glucocorticoid and NSAID administration is contraindicated in drug 233 
datasheets due to potential increased risk of gastric ulceration (National Office of Animal 234 
Health, 2017). Experimental studies in dogs concluded that concurrent administration of 235 
NSAIDs and glucocorticoids increased the risk of developing gastric mucosal erosions 236 
observed via endoscopy and faecal occult blood measurement (Dow et al., 1990, Boston et 237 
al., 2003, Narita et al., 2007). Evidence supporting NSAID administration as a cause of 238 
equine glandular gastric ulceration syndrome (EGGUS) at a population level is weak (Sykes 239 
and Jokisalo, 2015). Although there is potentially an increased risk of EGGUS with 240 
concurrent NSAID and corticosteroid administration, the authors felt that this risk was 241 
outweighed by the benefit of a potential reduction in peri-articular swelling, and as colic was 242 
a concern due to the aforementioned factors, the horse was monitored closely for signs of 243 
abdominal pain. 244 
 Although not licensed in horses, oral paracetamol was added to the treatment protocol 245 
when clinical signs did not improve with phenylbutazone. There is a paucity of literature on 246 
the analgesic efficacy of paracetamol in horses but there is a report of its successful use as an 247 
adjunctive analgesic to phenylbutazone in a pony with acute laminitis (West et al., 2011). 248 
Mechanism of action is different from NSAIDs as analgesia is thought to be centrally 249 
mediated, involving both cannabinoid and serotonergic pathways (Oscier and Milner, 2009).  250 
 Ketamine is a widely used anaesthetic agent in horses but its use as an analgesic in 251 
horses is not commonly reported. Ketamine, an N-methyl-D-aspartate (NMDA) receptor 252 
antagonist, is believed to mediate analgesia by preventing transmission of pain stimuli and 253 
modulating pain perception. In particular, ketamine may prevent hyperalgesia and central 254 
pain sensitisation, preventing development of chronic pain (Koizuka et al., 2005, 255 
Latremoliere and Woolf, 2009). Reports demonstrating this benefit in horses are however 256 
limited to pain management in chronic laminitis (Jones et al., 2007, Muir, 2010). Additional 257 
potential benefits of ketamine that have been demonstrated in rodent and human experimental 258 
studies include potentiation of opioid analgesia as well as reduction of opioid tolerance and 259 
side effects (Inturrisi, 1994, Lauline et al., 2002, Shulte et al., 2004, Zhang et al., 2009), but 260 
these effects have not been demonstrated in horses. It has been suggested that ketamine 261 
infusion rates ranging from 0.8 to 1.5 mg/kg bwt/hour in horses are likely to result in 262 
analgesia whilst reducing central sensitisation and hyperalgesia (Fielding et al., 2006, Muir, 263 
2010). As chronic pain is a reported consequence of compartment syndrome in humans 264 
(Lederman et al., 2016), in the authors' opinion it was logical to include ketamine in the 265 
analgesic protocol. Lameness dramatically reduced following 12 hours of ketamine infusion 266 
at 0.8mg/kg bwt/hour in this case, although concurrent epidural opioid administration 267 
precluded the ability to determine the analgesic effect of each drug individually.  268 
 Whilst the analgesic efficacy of opioids, particularly mu receptor agonists, in humans 269 
and other veterinary species is well reported, there are few studies that convincingly 270 
demonstrate the efficacy of opioid analgesics in horses. Inconsistent results and discrepancies 271 
exist between experimental and clinical studies (Lowe, 1978, Kamerling et al., 1985, Brunson 272 
and Majors, 1987, Kamerling et al., 1988, Bennett and Steffey, 2002). Intra-articular 273 
morphine could have been considered during arthroscopy in this case as this has been shown 274 
to reduce lameness scores in horses with experimentally induced synovitis compared to 275 
systemic morphine (Lindegaard et al., 2010). However, the authors considered the 276 
administration of systemic and epidural opioids pre-operatively in addition to intra-articular 277 
bupivacaine intra-operatively as provision of sufficient analgesia. Studies investigating 278 
epidural opioid administration have provided some of the most convincing evidence 279 
supporting use of opioids in providing analgesia in horses (Valverde et al., 1990, Robinson, 280 
1994, Bennett and Steffey, 2002, van Loon et al., 2012). Epidural opioid administration can 281 
produce segmental analgesia, resulting in a higher local concentration with longer analgesic 282 
duration as well as fewer CNS and cardiorespiratory side effects compared to systemic opioid 283 
administration (Natalini and Robinson, 2000, Torske and Dyson, 2000). Lipid solubility of 284 
opioids can affect onset and duration of analgesia when administered into the epidural space. 285 
Relatively hydrophilic compounds such as morphine have a slow onset of action but longer 286 
duration of action than more lipophilic agents such as methadone and fentanyl (Cousins and 287 
Mather, 1984, Natalini and Driessen, 2007). It is for this reason that methadone and morphine 288 
were administered concurrently following epidural catheter placement in this case. 289 
Methadone provides rapid onset of analgesia, whilst duration is enhanced with the inclusion 290 
of morphine (Olbrich and Mosing, 2003, Martin-Flores et al., 2014). Epidural administration 291 
of opioids was considered likely to be of benefit in this case to target the source of pain in the 292 
left pelvic limb, to allow a more convenient dosing interval of 12 hours instead of four hours 293 
with systemic morphine and to reduce reported systemic side effects associated with opioid 294 
usage in horses (Martin-Flores et al., 2014). Given the increasing severity of lameness and 295 
poor response to systemic opioids post-operatively, epidural opioid administration could have 296 
been considered earlier in this case. Placement of an epidural catheter facilitates regular 297 
opioid administration without the need to perform repeated needle punctures. Complications 298 
associated with the use of epidural catheters in horses include premature dislodgement, 299 
obstruction, leakage, inflammation around the catheter site, generalised muscle tremors, 300 
ataxia, pruritus and epidural steatitis with cauda equina neuritis symptoms (Martin et al., 301 
2003, Robinson and Natalini, 2002, Steblaj et al., 2013). The horse in this case was cross-tied 302 
after epidural catheter placement to reduce risk of dislodgement. Lameness dramatically 303 
reduced and mobility improved within 12 hours of epidural opioid administration but 304 
simultaneous commencement of epidural opioids and ketamine CRI made it difficult to assess 305 
which was most beneficial or whether there was a synergistic effect. 306 
 Assessment of pain in equids can be challenging and there is no universally accepted 307 
or validated pain scale in horses. Numerous pain scales have been designed to try to 308 
quantitatively assess pain due to various pathologies (Pritchett et al., 2003, Bussières et al., 309 
2008, Lindegaard et al., 2010, Wagner, 2010, van Loon and van Dierendonck, 2015). 310 
Lameness scoring (Stashak, 2002) was performed in this case as an indicator of improved 311 
mobility and hence response to analgesia but recent research has focused on assessment of 312 
facial expression to interpret pain (Dalla Costa et al., 2014, Gleerup et al., 2015, Dalla Costa 313 
et al., 2016). 'Low' positioning of ears and a tense stare were identified in this case, which 314 
were considered indicative of pain (Gleerup et al. 2015). Pain was assessed largely 315 
subjectively in this case and was managed accordingly although it would have been more 316 
advantageous to adopt a more structured and consistent method of assessing pain to monitor 317 
progress and response to analgesic medication more quantitatively. Palpation of the swollen 318 
area could have been performed to determine how the mare reacted. This can be assessed 319 
more objectively with the use of pressure algometers or von Frey filaments but these are not 320 
readily available in a clinical setting (Gleerup and Lindegaard, 2016). An Equine Pain Scale 321 
incorporating pertinent findings from previous studies which is quick and relatively easy to 322 
perform in a clinical setting has recently been proposed (Gleerup and Lindegaard, 2016). This 323 
could therefore be considered in similar cases in the future. 324 
 In conclusion, provision of multimodal analgesia played a pivotal role in the 325 
management of a suspected case of ECS. Reduction in pain allowed the mare to be walked 326 
out of the stable regularly, assisting in the resolution of swelling and leading to marked 327 
clinical improvement over a short period. Short-term outcome was favourable in this case but 328 
long-term follow up of this and similar cases in horses is recommended to identify any 329 
sequelae such as development of chronic pain, muscle contracture and sensory neuropathy as 330 
reported in humans and dogs (Taylor and Tangner, 2007, Frink et al., 2010, Lederman et al., 331 
2016).  332 
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  605 
Table 1 606 
Synovial fluid analysis on day of presentation at referral clinic 607 
Parameter  Result Reference Interval  Units 
Total nucleated cell count 12.9 <1 x109/L 
Lymphocytes 74.8 <20 % 
Monocytes and macrophages 2.3 >80 % 
Granulocytes 22.9 <10 % 
Red blood cells 2.42 <1 x1012/L 
Total protein 78 <25  g/L 
Microbiological culture No bacterial 
growth after 48 
hours 
N/A N/A 
 608 
  609 
Table 2 610 
Haematology results two days after arthroscopy 611 
Parameter  Result Reference Interval  Units 
White blood cells 6.22 4.3-14.8 x109/L 
Red blood cells 7.03 7.2-12 x1012/L 
Haemoglobin 12.7 11.6-18.9 g/dL 
Haematocrit 35 31-50 % 
MCV 49.8 35.7-53.9 fL 
MCH 18.1 11.9-20.3 pg 
MCHC 36.3 35-38.2 g/dL 
Platelets 116 69.9-250.8 x109/L 
Neutrophils 4.45 2.2-8.1 x109/L 
Lymphocytes 1.39 1.7-5.8 x109/L 
Monocytes 0.22 0-1 x109/L 
Eosinophils 0.14 0-0.8 x109/L 
Basophils 0.01 0-0.3 x109/L 
PT 10 16-20 seconds 
APTT 38 45-66 seconds 
Fibrinogen 242 100-400 mg/dL 
 612 
  613 
Table 3 614 
Day to day pain evaluation and analgesic management during hospitalisation 615 
Day(s) since 
admission to 
hospital 
Pain evaluation Analgesic management 
0 6/10 lame left pelvic limb 
(LPL) 
 4.4mg/kg bwt phenylbutazone IV q.12h 
1 (arthroscopy) 6/10 lame LPL  Intercoccygeal epidural with 60mg 
morphine and 50mg methadone 
 50mg intra-articular bupivacaine 
 4.4mg/kg bwt phenylbutazone IV q.12h 
2 9/10 lame LPL 
Marked peri-articular 
swelling around left stifle 
 4.4mg/kg bwt phenylbutazone IV q.12h 
 0.2mg/kg bwt morphine IV q.4h 
 20mg/kg bwt paracetamol PO q.12h 
 Distal portal sutures removed and cold 
packing/hosing commenced 
3 8/10 lame LPL 
Only mild reduction in peri-
articular swelling 
 4.4mg/kg bwt phenylbutazone IV q.12h 
 20mg/kg bwt paracetamol PO q.12h 
 0.2mg/kg bwt morphine IV q.4h 
 0.1mg/kg bwt dexamethasone IV 
 Cold packing and hosing continued 
4 9/10 lame LPL 
Low head carriage and 'low' 
ear position with tense face. 
 Lumbosacral epidural catheter placed - 
60mg morphine and 50mg methadone 
administered followed by 60mg 
Extremely reluctant to walk 
out of stable 
morphine q.12h 
 Ketamine CRI at 0.8mg/kg bwt/hour 
 4.4mg/kg bwt phenylbutazone IV q.12h 
 20mg/kg bwt paracetamol PO q.12h 
5 3/10 lame LPL 
Marked improvement in 
demeanour - normal head 
carriage and ear position 
 2.2mg/kg bwt phenylbutazone IV q.12h 
 20mg/kg bwt paracetamol PO q.12h 
 60mg epidural morphine q.12h 
 Ketamine CRI discontinued overnight 
(after 24 hours) 
6 5/10 lame LPL 
Demeanour and facial 
expression normal 
Peri-articular swelling 
reduced 
 2.2mg/kg bwt phenylbutazone PO q.12h 
 20mg/kg bwt paracetamol PO q.12h 
 60mg epidural morphine q.12h 
 Physical therapy commenced - local 
massage and 5 minutes in-hand walking 
q.8h 
7 4/10 lame LPL 
Tolerating physical therapy 
well 
 2.2mg/kg bwt phenylbutazone PO q.12h 
 20mg/kg bwt paracetamol PO q.12h 
 60mg epidural morphine q.12h 
 In-hand walking increased to 10 minutes 
q.8h 
8 3/10 lame LPL  2.2mg/kg bwt phenylbutazone PO q.12h 
 20mg/kg bwt paracetamol PO q.12h 
 30mg epidural morphine q.12h 
 Physical therapy continued 
9 2/10 lame LPL  2.2mg/kg bwt phenylbutazone PO q.12h 
 30mg epidural morphine q.12h 
 In-hand walking increased to 15 minutes 
q.8h 
10 2/10 lame LPL  2.2mg/kg bwt phenylbutazone PO q.12h 
 15mg epidural morphine q.12h 
11 1/10 lame LPL  2.2mg/kg bwt phenylbutazone PO q.12h 
 Epidural catheter removed 
12-15 1/10 lame LPL  2.2mg/kg bwt phenylbutazone PO q.12h 
 616 
  617 
Figure 1. Longitudinal ultrasound image of the craniolateral aspect of the left stifle 618 
showing intra-(arrows) and peri-articular (arrowheads) material of mixed echogenicity 619 
consistent with haemarthrosis within the femoropatellar joint and peri-articular 620 
haemorrhage, respectively (proximal is to the left). 621 
Key: * = lateral patellar ligament; † - lateral trochlear ridge; ‡ = joint capsule of the 622 
femoropatellar joint 623 
 624 
  625 
Figure 2. Photographs of the craniolateral (a) and caudal (b) aspects of the left 626 
stifle/thigh region 24 hours post-arthroscopy demonstrating marked swelling. 627 
Serosanguinous discharge is visible at arthroscopy portals after suture removal. 628 
 629 
  630 
Figure 3. Indwelling lumbosacral epidural catheter 631 
 632 
  633 
Figure 4. Photograph of caudal view of the pelvic limbs demonstrating marked 634 
reduction in swelling around left stifle/thigh after eight days of hospitalisation 635 
(immediately prior to epidural catheter removal). 636 
 637 
